We sought to determine the contributions of
protein tyrosine phosphatases (
PTPs) to the pathogenesis of
B-cell lymphomas. We found that T-cell PTP (
TC-PTP) was overexpressed in transformed B cells. We hypothesized that
TC-PTP may be a
tumor-promoting gene that is regulated by MYC overexpression in B cells. Knockdown of
TC-PTP in murine
tumors resulted in decreased cell viability in vitro because of an arrest in the G(1) phase of the cell cycle. Furthermore, cells with reduced
TC-PTP expression were unable to either engraft or expand in vivo. Taken together, these data indicate that
TC-PTP is required for B-cell
tumor maintenance. Our data also suggested a correlation between
TC-PTP expression and MYC overexpression. To investigate this further, we used malignant murine B cells that contain a
doxycycline-repressible MYC transgene. We found that repression of MYC overexpression with
doxycycline reduced
TC-PTP expression. Moreover, enforced expression of
TC-PTP showed partial rescue of the expansion of
tumor cells after suppression of MYC overexpression. These results suggest that MYC overexpression induces
TC-PTP overexpression, which in turn promotes
tumor proliferation, implicating
TC-PTP as an important effector of the MYC-driven proliferation program in
B-cell lymphomas. Thus,
TC-PTP may be a suitable molecular target for the treatment of
B-cell lymphomas.